Production of Hematopoietic and Immune System Growth Factors After Marrow Transplantation and Their Use in Enhancing Haematopoietic and Immune Reconstitution
A severe combined cellular and humoral immune deficiency is consistently seen after both autologous and allogeneic marrow transplantation in humans , One of the most striking defects is the slow and abnormal return of T lymphocyte numbers, resulting in a long-term deficiency of CD4-positive T cells and a normal or increased number of CD8-positive T cells. Not surprisingly, this results in defects of T cell function including lymphokine production. Lymphokines produced by activated T lymphocytes include growth factors for both the immune system and the hematopoietic system. B cell function is also seriously impaired with absent or minimal antibody production by B cells, both in vitro and in vivo.
KeywordsToxicity DMSO Leukemia Interferon Prostaglandin
Unable to display preview. Download preview PDF.
- 1.Noel DR, Witherspoon RP, Storb R, Atkinson K, Doney K, Mickelson EM, Ochs HD, Warren RP, Wielden PL, Thomas ED (1978) Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors. Blood 51: 1087–105PubMedGoogle Scholar
- 2.Atkinson K, Biggs JC, Noble G, Ashby M, Concannon A, Dodds A (1987) Preparative regimes for marrow transplantation containing Busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease, but a short duration of leucopenia and little oropharyngeal mucositis. Bone Marrow Transplant 2: 358–394Google Scholar
- 3.Atkinson K, Biggs JC, Concannon A, Dodds A, Downs K, Ashby M (1988) A prospective randomised trial of cyclosporin versus methotrexate after HLA-identical sibling marrow transplantation for patients with acute leukemia in first remission: analysis 2.5 years after last patient entry. Aust NZ J Med 18: 594–599CrossRefGoogle Scholar
- 4.Brkic S, Tsoi MS, Mori T, Lachman L, Gillis S, Thomas E, Storb R (1985) Cellular interactions in marrow-grafted patients. III. Normal interleukin 1 and defective interleukin 2 production in short term patients and in those with chronic graft-versus-host disease. Transplantation 39: 30–35PubMedCrossRefGoogle Scholar
- 8.Atkinson K, Goehle S, Hansen J, Thomas ED, Storb R (1982) Human T cell subpopulations identified by monoclonal antibodies after bone marrow transplantation. 1. Helper-inducer and cytotoxic-suppressor subsets. Blood 59: 1297–1298Google Scholar
- 9.Rozans MK, Smith BR, Burakoff SJ, Miller RA (1986) Long lasting deficit of functional T cell precursors in human bone marrow transplant recipients revealed by limiting dilution methods. J Immunol 136: 1–9Google Scholar
- 16.Masaoka T, Takaku F, Kato S, Moriyama Y, Kodera Y, Kanamaru A, Shimosaka A, Shibata H, Nakamura H (1989) Recombinant human granulocyte colony-stimulating factor in allogeneic bone marrow transplantation. Exp Hematol 17: 1050Google Scholar